Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Krag Knop

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Nutrition & Diabetes|January 14, 2018
Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetesMette Johannsen Mandøe, Katrine Bagge Hansen, Johanne Agerlin Windeløv, et al.
JHEP Reports : Innovation in Hepatology|June 25, 2021
Hepatic microbiome in healthy lean and obese humansMalte Palm Suppli, Jonatan Ising Bagger, Benjamin Lelouvier, et al.
Danish Medical Journal|March 4, 2021
Prognostic factors of 90-day mortality in patients hospitalised with COVID-19Christian Brieghel, Peter Ellekvist, Marie Louise Lund, et al.
Diabetes Care|October 22, 2021
Prediabetes Defined by First Measured HbA<sub>1c</sub> Predicts Higher Cardiovascular Risk Compared With HbA<sub>1c</sub> in the Diabetes Range: A Cohort Study of Nationwide RegistriesSam Kafai Yahyavi, Ole Snorgaard, Filip Krag Knop, et al.
Frontiers in Endocrinology|April 30, 2019
Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 DiabetesChristian Stevns Hansen, Christian Seerup Frandsen, Jesper Fleischer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2019
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without DiabetesNatasha Chidekel Bergmann, Asger Lund, Lærke Smidt Gasbjerg, et al.
The Journal of Clinical Endocrinology and Metabolism|April 20, 2024
Hemostatic Effects of Exercise-related Hypoglycemia in Male Persons With Type 1 DiabetesPer Gustav Hagelqvist, Andreas Andersen, Kaisar Maytham, et al.
BMC Cardiovascular Disorders|April 28, 2023
Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetesLaurits Juhl Heinsen, Gokulan Pararajasingam, Thomas Rueskov Andersen, et al.
Biomedicines|July 29, 2023
Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men-A Randomised Placebo-Controlled TrialPeter Kamstrup, Ema Rastoder, Pernille Høgh Hellmann, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 21, 2021
Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trialMark Krogh Hvistendahl, Rahim Mohammad Naimi, Svend Høime Hansen, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Nutrition & Diabetes|January 14, 2018
Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetesMette Johannsen Mandøe, Katrine Bagge Hansen, Johanne Agerlin Windeløv, et al.
JHEP Reports : Innovation in Hepatology|June 25, 2021
Hepatic microbiome in healthy lean and obese humansMalte Palm Suppli, Jonatan Ising Bagger, Benjamin Lelouvier, et al.
Danish Medical Journal|March 4, 2021
Prognostic factors of 90-day mortality in patients hospitalised with COVID-19Christian Brieghel, Peter Ellekvist, Marie Louise Lund, et al.
Diabetes Care|October 22, 2021
Prediabetes Defined by First Measured HbA<sub>1c</sub> Predicts Higher Cardiovascular Risk Compared With HbA<sub>1c</sub> in the Diabetes Range: A Cohort Study of Nationwide RegistriesSam Kafai Yahyavi, Ole Snorgaard, Filip Krag Knop, et al.
Frontiers in Endocrinology|April 30, 2019
Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 DiabetesChristian Stevns Hansen, Christian Seerup Frandsen, Jesper Fleischer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2019
Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men Without DiabetesNatasha Chidekel Bergmann, Asger Lund, Lærke Smidt Gasbjerg, et al.
The Journal of Clinical Endocrinology and Metabolism|April 20, 2024
Hemostatic Effects of Exercise-related Hypoglycemia in Male Persons With Type 1 DiabetesPer Gustav Hagelqvist, Andreas Andersen, Kaisar Maytham, et al.
BMC Cardiovascular Disorders|April 28, 2023
Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetesLaurits Juhl Heinsen, Gokulan Pararajasingam, Thomas Rueskov Andersen, et al.
Biomedicines|July 29, 2023
Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men-A Randomised Placebo-Controlled TrialPeter Kamstrup, Ema Rastoder, Pernille Høgh Hellmann, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|July 21, 2021
Bile acid-farnesoid X receptor-fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trialMark Krogh Hvistendahl, Rahim Mohammad Naimi, Svend Høime Hansen, et al.
Pageof 10